Table 1.
Disease/model | Test sample | Related bacteria | Specific changes | Reference |
---|---|---|---|---|
Breast cancer | Human Blood |
Citrobacter*, Bacteroides*, Bifidobacterium* |
Were 10–100 times higher in cancer patients than in healthy controls; | 16 |
Breast cancer | Human nipple aspirate fluid | Alistipes* | Was the most relatively abundant bacteria genus; | 33 |
Breast cancer | Human feces | Bacteroides* | Was closely related to cancer: every 1% increase in its relative abundance increased the incidence rate of breast cancer by 5%; | 34 |
Breast cancer | Human feces |
Romboutsia,* Coprococcus 2* |
Were strongest negative correlation with breast cancer: each 1% increase reduced the incidence rate of breast cancer by 91% and 55%, respectively; | 34 |
Breast cancer | Human feces | Faecalibacterium* | Was present in almost 100% of controls and only 90% of both case groups, and was most strongly, inversely associated with odds of breast cancer and nonmalignant breast disease; | 34 |
Breast cancer | Human feces | Christensenellaceae R-7 group, Dorea*, [Eubacterium] coprostanoligenes group*, Pseudobutyrivibrio, Lachnospira |
Were inversely associated with odds of breast cancer; | 34 |
Breast cancer | Human feces |
Flavonifractor, Ruminococcaceae* |
Were positively associated with breast cancer; | 34 |
Ovarian cancer | Human feces | Akkermansia (the unique genus in Verrucomicrobia phylumas) | Was remarkably reduced in the ovarian cancer and loss of the Akkermansia genus was a featuring characteristic of patients with ovarian cancer; | 35 |
Ovarian cancer | Mice feces |
Bacteroides*, Lactobacillus* |
The abundance of Bacteroides was increased but that of Lactobacillus was decreased in ovarian cancer mice; | 36 |
Endometrial cancer | Human feces |
Anaerostipes caccae, Ruminococcus sp.N15.MGS–57*, Prevotella sp.DJF_LS1653* |
Enriched in endometrial cancer and being associated with metabolites C16:1 and C20:2; | 37 |
Endometrial cancer | Human feces |
Prevotella*, Bacteroides* |
Were dominated in endometrial cancer patients; | 38 |
Endometriosis | Mice feces | Firmicutes*, Bacteroidetes* |
Firmicutes/Bacteroidetes ratio was elevated in mice with endometriosis; | 39 |
Endometriosis | Mice feces | Bifidobacterium* | Increased in mice with endometriosis; | 39 |
Endometriosis | Mice feces | Bacteroidetes*, Firmicutes* |
Higher abundance of Bacteroidetes and lower abundance of Firmicutes in the guts than mice without EMS; | 40 |
Postmenopausalwomen | Human feces |
Bacteroides sp. strain Ga6A1*, Prevotella marshii*, Sutterella wadsworthensis |
Enriched in postmenopause; | 41 |
Postmenopausalwomen | Human feces |
Escherichia coli-Shigella spp.*, Oscillibacter sp. strain KLE1745, Akkermansia muciniphila, Clostridium lactatifermentans*, Parabacteroides johnsonii*, Veillonella seminalis |
Depleted in postmenopause; | 41 |
OVX mice (menopause) |
Mice feces | Lactobacillaceae*, Ruminococcaceae*, Streptococcaceae* |
Was related to fecal β-glucuronidase activity; | 42 |
Postmenopausalwomen | Human feces | Lachnospiraceae, Ruminococcaceae* |
Were associated with estrogens and estrogen metabolites; | 43 |
Premenopausal women | Human feces | Bacteroides* | Was inversely related to the ratio of estrogen metabolites to maternal estrogens; | 44 |
Reproductive, premenopausal,postmenopausal women | Human feces | Clostridium* | As a predominance in all groups; | 45 |
Postmenopausal women | Human feces | Clostridium* | Lower levels of beta-estradiol in the presence of higher copy numbers of Clostridium; | 45 |
Postmenopausal women | Human feces | Non-Clostridiales*, three genera in the Ruminococcaceae* |
Were strongly associated with non-ovarian estrogen level | 46 |
Menopausal syndrome | Human feces | Aggregatibacter segnis, Bifidobacterium animalis*, Acinetobacter guillouiae | Had a positive correlation with E2 and decreased in menopausal syndrome; | 47 |
Menopausal syndrome | Human feces |
Ruminococcus torques*, Blautia obeum*, Butyricicoccus* pullicaecorum* |
Were positively correlated with Kupperman index scores; | 47 |
Menopausal syndrome | Human feces | Lactobacillus delbrueckii* | Was inversely correlated with Kupperman index scores; | 47 |
Menopausal hot flash | Human feces | Ruminococcus torques* | Was positively related to hot flash symptom score; | 47 |
Menopausal hot flash | Human feces | Clostridium cocleatum* | Was negatively related to hot flash symptom score; | 47 |
Menopausal hot flash | Human feces | Bifidobacterium*, Lactobacillus* | Showed a significant decrease; | 48 |
Menopausal hot flash | Human feces |
Klebsiella*, Clostridiodes difficile* |
Showed an increase; | 48 |
Premenopausal depression | Human feces | Klebsiella aerogenes* | Was higher in premenopausal women with depression than in those without depression | 32 |
Perimenopausal insomnia | Human feces |
Roseburia faecis*, Ruminococcus*, Prevotella copri*, Fusicatenibacter saccharivorans, Blautia obeum* |
Showed an increase in the abundance; | 49 |
Perimenopausal insomnia | Human feces |
Bacteroides*, Bacteroidetes*, Faecalibacterium prausnitzii* |
Showed a decrease in the abundance; | 49 |
Osteoporosis | Mice feces |
Ruminococcus flavefaciens*, Clostridium*, Coprococcus*, Robinsoniella |
Were positively correlated with osteoclastic indicators | 50 |
Osteoporosis | Mice feces |
Bacteroides*, Butyrivibrio* |
Were negatively correlated with loss of bone mass | 50 |
*Current gmGUS-encoding species have been known.